Literature DB >> 25947148

Molecular Engineering of Ghfp, the Gonococcal Orthologue of Neisseria meningitidis Factor H Binding Protein.

Valentina Rippa1, Laura Santini1, Paola Lo Surdo1, Francesca Cantini2, Daniele Veggi1, Maria Antonietta Gentile1, Eva Grassi1, Giulia Iannello1, Brunella Brunelli1, Francesca Ferlicca1, Emiliano Palmieri1, Michele Pallaoro1, Beatrice Aricò1, Lucia Banci3, Mariagrazia Pizza1, Maria Scarselli4.   

Abstract

Knowledge of the sequences and structures of proteins produced by microbial pathogens is continuously increasing. Besides offering the possibility of unraveling the mechanisms of pathogenesis at the molecular level, structural information provides new tools for vaccine development, such as the opportunity to improve viral and bacterial vaccine candidates by rational design. Structure-based rational design of antigens can optimize the epitope repertoire in terms of accessibility, stability, and variability. In the present study, we used epitope mapping information on the well-characterized antigen of Neisseria meningitidis factor H binding protein (fHbp) to engineer its gonococcal homologue, Ghfp. Meningococcal fHbp is typically classified in three distinct antigenic variants. We introduced epitopes of fHbp variant 1 onto the surface of Ghfp, which is naturally able to protect against meningococcal strains expressing fHbp of variants 2 and 3. Heterologous epitopes were successfully transplanted, as engineered Ghfp induced functional antibodies against all three fHbp variants. These results confirm that structural vaccinology represents a successful strategy for modulating immune responses, and it is a powerful tool for investigating the extension and localization of immunodominant epitopes.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25947148      PMCID: PMC4478525          DOI: 10.1128/CVI.00794-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  40 in total

1.  Dissecting protein-protein recognition sites.

Authors:  Pinak Chakrabarti; Joël Janin
Journal:  Proteins       Date:  2002-05-15

2.  Rational design of a meningococcal antigen inducing broad protective immunity.

Authors:  Maria Scarselli; Beatrice Aricò; Brunella Brunelli; Silvana Savino; Federica Di Marcello; Emmanuelle Palumbo; Daniele Veggi; Laura Ciucchi; Elena Cartocci; Matthew James Bottomley; Enrico Malito; Paola Lo Surdo; Maurizio Comanducci; Marzia Monica Giuliani; Francesca Cantini; Sara Dragonetti; Annalisa Colaprico; Francesco Doro; Patrizia Giannetti; Michele Pallaoro; Barbara Brogioni; Marta Tontini; Markus Hilleringmann; Vincenzo Nardi-Dei; Lucia Banci; Mariagrazia Pizza; Rino Rappuoli
Journal:  Sci Transl Med       Date:  2011-07-13       Impact factor: 17.956

3.  Computational characterization of B-cell epitopes.

Authors:  Nimrod D Rubinstein; Itay Mayrose; Dan Halperin; Daniel Yekutieli; Jonathan M Gershoni; Tal Pupko
Journal:  Mol Immunol       Date:  2007-11-26       Impact factor: 4.407

4.  Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial.

Authors:  Helen S Marshall; Peter C Richmond; Michael D Nissen; Qin Jiang; Annaliesa S Anderson; Kathrin U Jansen; Graham Reynolds; John B Ziegler; Shannon L Harris; Thomas R Jones; John L Perez
Journal:  Pediatr Infect Dis J       Date:  2012-10       Impact factor: 2.129

5.  Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies.

Authors:  Kate L Seib; Brunella Brunelli; Barbara Brogioni; Emmanuelle Palumbo; Stefania Bambini; Alessandro Muzzi; Federica DiMarcello; Sara Marchi; Arie van der Ende; Beatrice Aricó; Silvana Savino; Maria Scarselli; Maurizio Comanducci; Rino Rappuoli; Marzia M Giuliani; Mariagrazia Pizza
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

6.  Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine.

Authors:  Jo Anne Welsch; Raffaella Rossi; Maurizio Comanducci; Dan M Granoff
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

7.  Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein.

Authors:  Peter T Beernink; Jo Anne Welsch; Michal Bar-Lev; Oliver Koeberling; Maurizio Comanducci; Dan M Granoff
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

Review 8.  Interactions of protein antigens with antibodies.

Authors:  D R Davies; G H Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  Vaccine potential of the Neisseria meningitidis 2086 lipoprotein.

Authors:  Leah D Fletcher; Liesel Bernfield; Vicki Barniak; John E Farley; Alan Howell; Melissa Knauf; Peggy Ooi; Robert P Smith; Paige Weise; Mike Wetherell; Xiaoling Xie; Robert Zagursky; Ying Zhang; Gary W Zlotnick
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates.

Authors:  Muriel C Schneider; Beverly E Prosser; Joseph J E Caesar; Elisabeth Kugelberg; Su Li; Qian Zhang; Sadik Quoraishi; Janet E Lovett; Janet E Deane; Robert B Sim; Pietro Roversi; Steven Johnson; Christoph M Tang; Susan M Lea
Journal:  Nature       Date:  2009-02-18       Impact factor: 49.962

View more
  3 in total

1.  Structural characterization of a cross-protective natural chimera of factor H binding protein from meningococcal serogroup B strain NL096.

Authors:  Daniele Veggi; Enrico Malito; Paola Lo Surdo; Werner Pansegrau; Valentina Rippa; Newton Wahome; Silvana Savino; Vega Masignani; Mariagrazia Pizza; Matthew J Bottomley
Journal:  Comput Struct Biotechnol J       Date:  2022-04-18       Impact factor: 6.155

Review 2.  Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens.

Authors:  Lassi Liljeroos; Enrico Malito; Ilaria Ferlenghi; Matthew James Bottomley
Journal:  J Immunol Res       Date:  2015-10-07       Impact factor: 4.818

3.  The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement.

Authors:  Thiago F A Rosa; Ansgar Flammersfeld; Che J Ngwa; Meike Kiesow; Rainer Fischer; Peter F Zipfel; Christine Skerka; Gabriele Pradel
Journal:  Cell Microbiol       Date:  2015-11-12       Impact factor: 3.715

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.